Friday, 15 February 2008
Kenyan consumers at highest risk of fake drugs
Business Daily reports that Kenyans have been listed among African consumers at highest risk of exposure to counterfeit drugs. In Kenya a National Quality Control Laboratories and Pharmacy and Poisons Board survey, conducted two years ago, found that nearly 30% of the drugs in the domestic market are counterfeit. The situation has reportedly since worsened, with the Kenyan Association of Pharmaceutical Industry estimating that some $130 million worth of counterfeit pharmaceutical products are sold in the market annually. This has repercussions for the market as well as for consumers: last year, Chinese company Holley-Cotec Pharmaceuticals was forced to recall 20,000 doses of its Duo-cotexin malaria drugs after it discovered that an illegal ring was manufacturing a version with low active ingredients and selling it at one fifth of the market price.